BioSpace News Archive

Entheon confirms that the CHDR, the Company’s Netherlands-based partner clinical research organization, has received an amendment to its opioid license, enabling it to possess and conduct research with DMT.

Regularly testing New England Biolabs employees helps maintain the supply of enzymes for crucial scientific research, including developing COVID-19 vaccines.

Viriom Inc (Viriom) announces that its antiviral drug Elpida®(elsulfavirine) has been included in the preferred first-line antiretroviral therapy (ART) regimens by the Ministry of Health of the Russian Federation according to updated clinical guidelines for the treatment of HIV infection in adults and children.

Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases.

Harvey H. McKenzie is a (Life Member) Chartered Professional Accountant (CPA-CA), granted by the Chartered Professional Accountants of Ontario will be an advisory consultant for CVR Medical and has agreed to a nomination to the Board of Directors.

Sirnaomics, Inc. , a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases, today announced that it will be presenting results from a recently completed Phase 2a clinical study of the company’s lead drug candidate,

CVS Health Corporation will hold a conference call with analysts and investors on Tuesday, February 16, 2021, at 8:00 a.m. to discuss its financial results for the fourth quarter of 2020.

Dr. Henderson’s career includes contributions in toxicology, spanning 30 years of research at Lovelace Biomedical.

Hawaii is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country

Massachusetts is among an initial 11 state rollout and part of the company’s larger plan to expand access to COVID-19 vaccines at CVS Pharmacy locations across the country